...
首页> 外文期刊>The Journal of Nuclear Medicine >Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients
【24h】

Gleason Score at Diagnosis Predicts the Rate of Detection of 18F-Choline PET/CT Performed When Biochemical Evidence Indicates Recurrence of Prostate Cancer: Experience with 1,000 Patients

机译:诊断时的格里森评分可预测生化证据表明前列腺癌复发时进行18F-胆碱PET / CT的检出率:有1000名患者的经验

获取原文

摘要

id="p-2">The objective of this study was to explore the ability of the initial Gleason score (GS) to predict the rate of detection of recurrent prostate cancer (PCa) with 18F-choline PET/CT in a large cohort of patients. >Methods: Data from 1,000 patients who had undergone 18F-choline PET/CT because of biochemical evidence of relapse of PCa between 2004 and 2013 were retrieved from databases at 4 centers. Continuous data were compared by the Student t test or ANOVA, and categoric variables were compared by the ??2 test. Univariable and multivariable analyses were performed by logistic regression. >Results: The GS at diagnosis was less than or equal to 6 in 257 patients, 7 in 347 patients, and greater than 7 in 396 patients. The results of 645 PET/CT scans were positive for PCa recurrence. Eighty-one percent of the positive PET/CT results were found in patients with a PSA level of greater than or equal to 2 ng/mL, 43% were found in patients with a PSA level of 1-2 ng/mL, and 31% were found in patients with a PSA level of less than or equal to 1 ng/mL; 78.8% of patients with positive PET/CT results had a GS of greater than 7. The results of 18F-choline PET/CT scans were negative in 300 patients; 44% had a GS of less than or equal to 6, 35% had a GS of 7, and 17% had a GS of greater than 7. PET/CT results were rated as doubtful in only 5.5% of patients (median PSA, 1.8 ng/mL). When the GS was greater than 7, the rates of detection of 18F-choline PET/CT were 51%, 65%, and 91% for a PSA level of less than 1 ng/mL, 1-2 ng/mL, and greater than 2 ng/mL, respectively. In univariable and multivariable analyses, both a GS of 7 and a GS of greater than 7 were independent predictors for positive 18F-choline PET/CT results (odds ratios, 0.226 and 0.330, respectively; P values for both, 0.001). >Conclusion: A high GS at diagnosis is a strong predictive factor for positive 18F-choline PET/CT scan results for recurrent PCa, even when the PSA level is low (i.e., a‰¤1 ng/mL).
机译:id =“ p-2”>本研究的目的是探索初始格里森评分(GS)预测 18 复发性前列腺癌(PCa)的检出率的能力。大量患者中的F-胆碱PET / CT。 >方法:从4个中心的数据库中检索了1000名因2004年至2013年间PCa复发的生化证据而进行了 18 F-胆碱PET / CT的患者的数据。通过Student t 检验或ANOVA比较连续数据,并通过?? 2 检验比较分类变量。通过逻辑回归进行单变量和多变量分析。 >结果: 257例患者的诊断GS小于或等于6,347例患者的GS小于或等于7,396例患者的GS小于或等于7。 645次PET / CT扫描结果PCa复发为阳性。 PSA水平大于或等于2 ng / mL的患者中有81%的PET / CT阳性结果,PSA水平为1-2 ng / mL的患者中发现了43%的PET / CT结果,31 PSA水平小于或等于1 ng / mL的患者中发现%; PET / CT结果阳性的患者中有78.8%的GS大于7。300名患者的 18 F-胆碱PET / CT扫描结果为阴性。 GS小于或等于6的患者占44%,GS大于7的患者占35%,GS大于7的患者占17%。PET/ CT检查结果仅对5.5%的患者表示可疑(PSA中位数, 1.8 ng / mL)。当GS大于7时,PSA低于1 ng / mL,1的 18 F-胆碱PET / CT的检出率分别为51%,65%和91%。分别为-2 ng / mL和大于2 ng / mL。在单变量和多变量分析中,GS≥7和GS≥7都是 18 F胆碱PET / CT阳性结果的独立预测因子(比值分别为0.226和0.330; P 值,<0.001)。 >结论:诊断中的高GS是复发PCa的 18 F-胆碱PET / CT扫描阳性结果的强有力的预测因素,即使PSA水平较低(即,a‰¤1ng / mL)。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号